We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Fc Receptor Protein Collection
Product News

Fc Receptor Protein Collection

Fc Receptor Protein Collection
Product News

Fc Receptor Protein Collection


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Fc Receptor Protein Collection"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

AMSBIO has announced an extensive collection of recombinant Fc receptor proteins, including their common variants, to help accelerate the development of therapeutic monoclonal antibodies (mAb).

Therapeutic antibody efficacy depends not only on the Fab fragment and its binding activity to the target antigen, but also depends on the Fc fragment and its interaction with key Fc receptors.

As a consequence screening for desired binding affinity to the key Fc receptors is an essential component in the development of a high quality therapeutic mAb.

Recombinant Fc Receptor proteins from AMSBIO are uniquely suitable for pharmaceutical research. All proteins are analyzed by SDS-PAGE and HPLC to guarantee their high purity / quality and supplied binding quality validated by both Surface Plasmon Resonance and ELISA.

Being expressed in HEK293 cells these recombinant Fc Receptor proteins retain their authentic post-translational processing leading to high bioactivity and stability.

The proteins are also available in a ready-to-use biotinylated format that makes assay development much faster and easier. The biotin-labelled proteins from AMSBIO are produced using proprietary in-house labelling techniques, which maintains the high bioactivity and avoids batch-to-batch variation.

Advertisement